An observational study in Hypoxia and Hemodilution, sponsored by Nihon Kohden. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-31.
Sponsored by Nihon Kohden · Observational
This study will collect physiological measurements in healthy adult volunteers under controlled hypoxia and hemodilution conditions.
Subjects will undergo stepwise reductions in oxygen saturation and hemoglobin concentration while noninvasive monitoring data are recorded and compared with reference blood measurements.
1,231 studies on the registry are indexed under Hypoxia; 242 are open to participants now.
This study's planned enrollment of 7 is below the median of 67 across 335 observational studies indexed under Hypoxia.
Browse Hypoxia studies →Nihon Kohden is the lead sponsor of 16 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Healthy adult volunteers. At least 7 subjects will be enrolled. Subjects will be selected with reference to ISO and FDA requirements to ensure appropriate representation across skin tone categories (Monk Skin Tone scale) and sex.
4. Has provided written informed consent and is willing to comply with study procedures.
Exclusion Criteria:
Adult healthy subjects capable of undergoing controlled hypoxemia and hemodilution procedures.
Device: Noninvasive Physiological Monitoring Device
Octopal R Noninvasive Pulse Wave Measuring Device DMO-8000X with TL 811S Finger Probe
Collection of Hemoglobin and Oxygen Saturation Measurements
Collect device readings of oxygen saturation and hemoglobin concentration and reference values obtained from arterial blood samples analyzed using a multi-wavelength laboratory oximeter.
Time frame: From enrollment to the end of treatment up to 8 hours
Plan to share: No — Company confidential
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nihon Kohden